Worldwide Healthcare

Overview Performance Charges & gearing Portfolio Management Structure

Data as at: 25/01/2021

Website Company website
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
Management group
Frostrow Capital
AIC sector
Biotechnology & Healthcare
Launch date
28/04/1995
Financial year end
March
Domicile
United Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Total assets (m) Price (last close) Price (bid) Price (offer) NAV Dividend dates Discount / premium (%) Gearing (%) 5yr dividend growth (%) p.a. Dividend yield (%)
2,539.63 3,895.00 3,885.00 3,900.00 3,906.10 Jun, Nov -0.3 1 14.9 0.6

Dividends

Dividends displayed in traded currency.

Ex-Dividend date Dividend amount Dividend type Special dividend Financial year
19/11/2020 6.500 Income No 2021
04/06/2020 18.500 Income No 2020

View dividend history

Dividend cover (years) Revenue reserves (m)
1.16 18.30

Trading information

ISIN TIDM Traded currency
GB0003385308 WWH GBX

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 209,031 2,630,743 32,174,196 98,157,109
Average N/A 142,179 127,459 77,117

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 8.14 100.74 1,104.99 2,711.99
Average N/A 5.46 4.38 2.13

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.